Terumo Signs Consent Decree with the FDA (Press Release)
During an inspection last year at Terumo Cardiovascular Systems Ann Arbor, Mich., plant, FDA officials found numerous violations to good manufacturing practice and medical device reporting requirements. On March 17, Terumo executive officers signed a consent decree of permanent injunction and under its terms, Terumo will pay almost $35 million in profits from past sales to the federal government.
